A 38-year-old woman with metastatic colorectal cancer is being evaluated for 5-fluorouracil (5-FU) toxicity after developing severe hand–foot syndrome and mucositis. Which investigation would be most appropriate to identify patients at risk for severe 5-FU toxicity due to dihydropyrimidine dehydrogenase (DPD) deficiency?